Inhalation Sciences' news roundup: 2.4 MSEK sale, new patent, upcoming China installation
With a major 2.4 MSEK sale, a new European patent and the upcoming installation of ISAB's first PreciseInhale system in China - September and October have been eventful and dynamic for Sweden's inhalation R&D innovators.ZICCUM AB SHARE ISSUE OVERSUBSCRIBED 234% before listing on Spotlight ISAB spinout company Ziccum attracted 1,000 new shareholders ahead of its listing on Spotlight. Ziccum's technology can formulate liquid biologic therapies and vaccines - as dry powders. Making them more cost-effective and easy-to-transport. CEO Göran Conradson: "It's gratifying that the new issue has